Alzheimer's: Overactive Brain Immune Cells Linked to Sleep Loss, Study Finds
Scientists have identified a novel cause for sleep disturbances in Alzheimer's disease, discovering that the brain's own immune cells, known as microglia, are implicated. In studies involving mice engineered to have amyloid plaques, researchers observed that overactive microglia initiated inflammation. This inflammatory response was found to disrupt the brain's ability to achieve deep, restorative sleep. Remarkably, the temporary removal of a significant portion of these microglia cells led to a restoration of more than two hours of sleep daily. This improvement occurred despite the continued presence of the amyloid plaques, suggesting a mechanism independent of plaque clearance.
This research highlights a potential paradigm shift in understanding Alzheimer's pathology, moving beyond solely focusing on amyloid plaques. The findings suggest that neuroinflammation driven by microglia may be a critical factor in sleep disruption, a common symptom in Alzheimer's patients. Future therapeutic strategies could explore modulating microglial activity to improve sleep quality and potentially slow cognitive decline, independent of plaque-clearing mechanisms. This approach warrants further investigation into the long-term effects and safety of targeting microglia in the context of neurodegenerative diseases.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.